SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
sciclone pharmaceuticals
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1137 26 0 SCLN
Emcee:  Skywatcher Type:  Unmoderated
This company is a Bay area company that's most important product
is in phase III testing in Taiwan for the treatment of Hepititus
B, which is one of the most difficult to treat and prevelant
especially in this region, including a massive problem in China.
Taiwan currently has a 17% CHB infection rate.
They have recently taken a beating with a report on this test in
Taiwan, when the stock took a dive from 13 to 7.5. But the stock
watcher who issued this downgrade really didn't look at the whole
study. The results were much better than he realized and the gov't
of Taiwan is going to request that the drug be introduced in the
first quarter of 97 due to the need to address the Hepatitus threat
in their country.
Drug name is Zadaxin. It has shown no systemic or toxic side effects.
China's approval is on track for Sept based on very significant
results from a 1 year test with over 150 subjects.
Schering Plough KK (japanese sub) will begin tests (III) in Sept
and the market for this drug in the Asian market alone is staggering.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1137sure you do.Brasco One-3/14/2012
1136almost hit 7 today...I always buy below 3...always pays off eventuallySkywatcher-3/14/2012
1135Finally a BIG DAY and GREAT EARNINGSSkywatcher-3/14/2012
1134been so long, I've just held it and don't even care anymore... it would Skywatcher-4/7/2009
1133The stock seems to be heading up, and there is news of new deals with Sigma Tau energyplay-4/7/2009
1132siliconinvestor.comDewDiligence_on_SI-2/11/2008
1131SciClone and Sigma-Tau Report Promising Interim Results From Phase 3 Hepatitis CSkywatcher-2/11/2008
1130more good news on the Melanoma drug...need some new products to start making anySkywatcher-6/4/2007
1129Today is THE DAY finally SciClone says melanoma trial showed positive survival Skywatcher-12/22/2006
1128Alfred Rudolph, M.D. Is Leaving as Chief Operating Officer Monday November 20, 6Skywatcher-11/20/2006
1127SciClone's Outlook Gets Better By Althea Chang TheStreet.com Staff ReporteSkywatcher-10/31/2006
1126I guess there's always hope....very little at this pointSkywatcher-7/30/2006
1125WATCH ZADAXIN!! Zadaxin is a proven antiviral adjuvant (enhancer)---just what GMaven1-7/30/2006
1124looks like AVII ain't doing well on HEP C either, stock down 33% today AVI BSkywatcher-5/10/2006
1123dude...you still alive....SCLN IS!!!! another day of the MM;s taking it down witSkywatcher-8/4/2005
1122It doesn't get any worse than this.....what a bomb! I wish we'd get on SSkywatcher-3/24/2004
1121LOL, ...too weird, ...I started my diet 7 months ago and by November had lost moJEB-3/3/2004
1120forget OT...there's nobody else in here.... did the workout thing for solid Skywatcher-3/3/2004
1119OT - You've got that right, ...Atkins is one scary diet! Btw, ...Wtg dumpinJEB-3/3/2004
1118sickening was the earnings..... I dropped 35 this past year....no atkins crap...Skywatcher-3/3/2004
1117Hi Chris, It's quiet around here. When you say "sickening", do yJEB-3/3/2004
1116SICKENING CCSkywatcher-2/24/2004
1115So no one has a take on the 2100 calls bought at .40 for December 7.50's????Skywatcher-10/8/2003
1114FIRST OF TWO PHASE 3 HEPATITIS C TRIALS SAN MATEO, CA – September 24, 2003 – ScSkywatcher-9/24/2003
1113I don't know...don't know if anyone does....I guess the fact that the SASkywatcher-7/29/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):